Raided German CBD sellers left in limbo with no legal charges yet

Written by CBD-Intel || 10th September 2019 || Regulatory briefing |

Europe

Germany

Regulation and Legislation

Regulatory briefing

Five months after police in Bavaria and Baden-Württemberg raided CBD shops and confiscated goods worth hundreds of thousands of euros, no charges have yet been filed ...

CBD regulatory news in brief, 3rd – 9th September

Written by CBD-Intel || 9th September 2019 || Regulatory briefing |

Asia

Australasia

Australia

Belgium

Europe

Germany

Ireland

Myanmar

Sweden

Thailand

Companies

Market Research

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state Victoria may yet...

California hemp bill delays legalisation of foods, beverages and cosmetics with hemp-based CBD

Written by Freddie Dawson || 9th September 2019 || Regulatory briefing |

California

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which ends on on...

A step forward as US DEA expands cannabinoid scientific research

Written by Freddie Dawson || 5th September 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Drug Enforcement Agency has decided to expand cannabinoid scientific research and no longer requires registration for the growth or research of hemp ...

Russia poised to open up to CBD after Duma agrees to lift cultivation ban

Written by CBD-Intel || 5th September 2019 || Regulatory briefing |

Russia

World

Regulation and Legislation

Regulatory briefing

Despite continuing uncertainty, the Russian CBD market is on the verge of big changes, following the approval of a draft bill by the national parliament ...

CBD-Intel regulatory news in brief, 27th August-2nd September

Written by CBD-Intel || 2nd September 2019 || Regulatory briefing |

Africa

Canada

Czech Republic

Europe

Ireland

Mexico

North America

Portugal

South Africa

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal ...

CBD drug Epidyolex looks unlikely to get a NICE answer in the UK

Written by CBD-Intel || 29th August 2019 || Regulatory briefing |

Europe

United Kingdom

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex ...

CBD-Intel regulatory news in brief, 19th-23rd August 2019

Written by CBD-Intel || 26th August 2019 || Regulatory briefing |

Asia

Austria

Croatia

Europe

Germany

Israel

Italy

North America

North Carolina

Slovakia

South Dakota

United States

Washington

Policy and Politics

Regulation and Legislation

Regulatory briefing

Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight ...

In the zone – Colombia’s promised new rules lead to optimism over exports

Written by CBD-Intel || 23rd August 2019 || Regulatory briefing |

Colombia

South America

Regulation and Legislation

Regulatory briefing

A new government decree in Colombia is expected to boost the hemp/cannabis export market by as early as the end of 2019, leading to optimism about the industry in the country ...

Italians sell CBD flowers as ‘animal feed’ to avoid confused enforcement

Written by CBD-Intel || 21st August 2019 || Regulatory briefing |

Europe

Italy

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Some Italian companies have begun to register CBD hemp flower products as animal feed in an attempt to avoid regulatory confusion and uneven enforcement in the country ...

CannTrust’s future cast in doubt after renewed troubles with Health Canada

Written by CBD-Intel || 20th August 2019 || Regulatory briefing |

Canada

North America

Companies

Regulation and Legislation

Regulatory briefing

The future of one of Canada's largest cannabis companies is hanging in the balance after a whistleblower and an unannounced inspection by Health Canada triggered a series of problems for CannTrust ...

Mexico holds open talks in move towards legalisation of cannabis

Written by CBD-Intel || 19th August 2019 || Regulatory briefing |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 19th August 2019 || Regulatory briefing |

Asia

California

Europe

Germany

Italy

New Jersey

North America

South Dakota

Spain

Thailand

United Kingdom

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey ...

First Jersey hemp licence issued – ‘a significant opportunity’ for island

Written by Freddie Dawson || 14th August 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Hemp can now be grown on the Channel Island of Jersey following the issuance of the first licence to harvest, process and store hemp flower in preparation for CBD...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 12th August 2019 || Regulatory briefing |

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Switzerland, Belgium, the UK, and the...

CBD-Intel bonus midweek regulatory alerts, 8th August 2019

Written by CBD-Intel || 8th August 2019 || Regulatory briefing |

Africa

Canada

Colombia

EU

Europe

Mexico

North America

South America

United States

Zimbabwe

Companies

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 5th August 2019 || Regulatory briefing |

Africa

Arizona

Canada

EU

Europe

Germany

Italy

Luxemburg

Netherlands

North America

North Carolina

Ohio

South Africa

South Carolina

Spain

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa ...

MHRA enforces CBD rules with British store

Written by CBD-Intel || 1st August 2019 || Regulatory briefing |

England

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health...

Epidyolex takes huge step toward EU licensing

Written by CBD-Intel || 31st July 2019 || Regulatory briefing |

EU

Europe

Companies

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European...

US urgently needs hemp regulations, Senate is told

Written by CBD-Intel || 30th July 2019 || Regulatory briefing |

North America

United States

Regulatory briefing

Rising demand for hemp products could soon make it an important cash crop for America but both industry and regulators must change to meet evolving demands and...

CannTrust leaders axed, confusion in Italy: regulatory news in brief

Written by CBD-Intel || 29th July 2019 || Regulatory briefing |

Canada

Europe

Italy

New York

North America

North Carolina

Portugal

Texas

United States

Washington

Regulation and Legislation

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal ...

No Euphoria here – Ireland recalls Dutch oil from sale over THC content

Written by CBD-Intel || 26th July 2019 || Regulatory briefing |

EU

Europe

Ireland

Regulation and Legislation

Regulatory briefing

A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC ...

Curaleaf in hot water with FDA over ‘improper health claims’

Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...

Poland’s bizarre rules mean CBD oil is taxed as food but labelled non-edible

Written by CBD-Intel || 25th July 2019 || Regulatory briefing |

Europe

Poland

Regulation and Legislation

Regulatory briefing

The Polish CBD sector is beset by confusing regulation and uneven enforcement – but it does benefit from a reduced rate of VAT, below even that of prescription medical cannabis ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 24th July 2019 || Regulatory briefing |

Belgium

Europe

Germany

Italy

North America

North Dakota

United Kingdom

United States

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium ...

Is Serbia set to place ‘psychoactive’ CBD on the controlled list?

Written by Marija Obradovic || 23rd July 2019 || Regulatory briefing |

Europe

Serbia

Regulation and Legislation

Regulatory briefing

A tough regulatory regime in Serbia may soon become even tougher as the Commission for Psychoactive Controlled Substances believes CBD should be a scheduled substance ...

Health Canada steps up vigilance, with clamps on Agrima and CannTrust

Written by CBD-Intel || 22nd July 2019 || Regulatory briefing |

Canada

North America

Regulation and Legislation

Regulatory briefing

Health Canada has revoked the licence of producer Agrima Botanicals and put a hold on product grown by CannTrust ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 22nd July 2019 || Regulatory briefing |

Asia

California

China

Czech Republic

EU

Europe

France

Germany

Ireland

Italy

Latvia

North America

Ohio

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China ...

US senators push for law change to ease research into CBD and cannabis

Written by CBD-Intel || 18th July 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction ...

Italy’s Supreme Court explanation leaves ‘psychotropic effect’ unclear

Written by CBD-Intel || 18th July 2019 || Regulatory briefing |

EU

Europe

Italy

Regulation and Legislation

Regulatory briefing

Italy’s Supreme Court has published the reasoning behind its ruling that cannabis products are illegal except for those without psychotropic effects – without adding any clarity ...

Congressional pressure builds in favour of progress on CBD

Written by CBD-Intel || 17th July 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Attention in Washington is increasingly focused on CBD, with the US Congress striving to address regulation and the FDA promising policy action soon ...

It’s business as unusual over CBD in topsy-turvy Washington circles

Written by CBD-Intel || 15th July 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD has turned Washington upside down, with a legal expert at the conservative Heritage Foundation testifying to Congress on behalf of federalism over states’ rights and free enterprise ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 15th July 2019 || Regulatory briefing |

Australasia

Delaware

Europe

Italy

Kentucky

New Zealand

North America

South Dakota

Turkey

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam ...

Call for UK authority to regulate and trial cannabis-based medicines

Written by CBD-Intel || 11th July 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

The UK Centre for Medical Cannabis (CMC) has called for a Cannabinoid Clinical Trials Authority to regulate and test cannabis-based medicinal products ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 11th July 2019 || Regulatory briefing |

Argentina

Estonia

Europe

Iowa

Lithuania

North America

South America

Turkey

United States

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa ...

Taxed and raided – Irish CBD sellers caught in a double jeopardy

Written by CBD-Intel || 9th July 2019 || Regulatory briefing |

Europe

Ireland

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Irish retailers have complained that their small shops have been raided by police and CBD stocks seized – even though they are also expected to pay tax on the products ...

Massachusetts upsets farmers by insisting on no CBD in food products

Written by Daniel Mollenkamp || 8th July 2019 || Regulatory briefing |

Massachusetts

North America

United States

Regulation and Legislation

Regulatory briefing

The Massachusetts Department of Agricultural Resources has confirmed that farmers and processors in the state cannot add CBD to food ingredients ...

CBD-Intel regulatory news in brief, 1st-5th July 2019

Written by CBD-Intel || 8th July 2019 || Regulatory briefing |

Belgium

Europe

Germany

Italy

Kansas

Massachusetts

New York

North America

United States

Regulation and Legislation

Regulatory briefing

This week’s round-up of regulatory news in the global CBD market includes updates from US federal authorities, Kansas, Massachusetts, New York City, Belgium, Germany and Italy ...

UK health committee says more research will lead to greater trust

Written by CBD-Intel || 4th July 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A group of British MPs is recommending that more trials and research are carried out into cannabis-based medical products (CBMPs), including those containing CBD ...

Health Canada opens consultation on prescription-free CBD health products

Written by CBD-Intel || 4th July 2019 || Regulatory briefing |

Canada

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Canadian government has taken a first step towards allowing health products containing CBD – and potentially other cannabinoids – without a prescription ...

Pyramid seller and UK regulator stay relaxed over reps’ unauthorised claims

Written by Freddie Dawson || 1st July 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

UK authorities may take no action, and US multi-level marketing company HempWorx will not discipline its British affiliate sellers, over online posts making health claims ...

CBD-Intel regulatory news in brief, 24th-28th June

Written by CBD-Intel || 1st July 2019 || Regulatory briefing |

Canada

Delaware

EU

Europe

Florida

Germany

Iowa

North America

Oregon

Turkey

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from the US, Canada, EU, Germany, Turkey and the United Nations ...

USDA counsel says states cannot halt transport of legally-grown hemp

Written by Daniel Mollenkamp || 25th June 2019 || Regulatory briefing |

Colorado

Idaho

North America

Oregon

United States

West Virginia

Regulation and Legislation

Regulatory briefing

US states and tribal territories have no right to stop the transportation of legal hemp that conforms with US Department of Agriculture (USDA) guidelines or was produced under the terms of the 2014 Farm Bill ...

CBD-Intel regulatory news in brief, 17th-21st June

Written by CBD-Intel || 24th June 2019 || Regulatory briefing |

Belgium

Colombia

Europe

Florida

France

Latvia

Massachusetts

New Mexico

North America

North Dakota

Oregon

South America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel, with updates from around the US, Belgium, France, Latvia, and Colombia ...

Sweden’s Supreme Court rules any trace of THC makes CBD a narcotic

Written by CBD-Intel || 19th June 2019 || Regulatory briefing |

Europe

Sweden

Regulation and Legislation

Regulatory briefing

In a potentially serious blow to businesses and users in Sweden, CBD oil containing low levels of THC will be classed as a narcotic following a ruling by the Swedish Supreme Court ...

Euro confusion could take vital CBD off the shelves, expert warns

Written by CBD-Intel || 19th June 2019 || Regulatory briefing |

EU

Europe

United Kingdom

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A murky legal situation and lack of government direction continue to hold back CBD in the UK and Europe, according to a keynote speaker at next month’s Europe CBD Expo in London ...

South Africa legalises lower doses of CBD – but only for a trial year

Written by CBD-Intel || 18th June 2019 || Regulatory briefing |

Africa

South Africa

Policy and Politics

Regulation and Legislation

Regulatory briefing

A landmark decision by South Africa's now former health minister Aaron Motsoledi has legalised lower dosage CBD. But there's a catch – the ruling only applies until May 2020 ...

FDA considers the question of routes to market for non-pharma CBD

Written by Freddie Dawson || 18th June 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US FDA has confirmed its commitment to creating an alternative route to market for non-pharmaceutical CBD products such as foods and dietary supplements – eventually ...

CBD regulatory news in brief,
10th-16th June 2019

Written by CBD-Intel || 17th June 2019 || Regulatory briefing |

Australasia

Australia

Brazil

Canada

Colombia

Croatia

Europe

Germany

Illinois

Louisiana

Luxemburg

Nebraska

Nevada

North America

Oregon

Portugal

South America

Texas

United States

Regulation and Legislation

Regulatory briefing

A round-up of the week’s relevant regulatory news in the global CBD market for CBD-Intel ...

Relabelling to sidestep novel food rules could be a risky business

Written by CBD-Intel || 13th June 2019 || Regulatory briefing |

Austria

Bulgaria

Czech Republic

EU

Europe

Germany

Companies

Regulation and Legislation

Regulatory briefing

Some European makers of CBD products have come up with a way to dodge requirements for novel foods – relabelling. But critics warn that could be risky ...